Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × sacituzumab govitecan × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Triple Negative Breast Neoplasms 5 Carcinoma, Transitional Cell 5 Urinary Bladder Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Small Cell Lung Carcinoma 2 Endometrial Neoplasms 2 Uterine Cervical Neoplasms 1 Urothelial Bladder Carcinoma 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Metastatic Urothelial Cancer 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1 Liver Failure 1 Laryngeal Neoplasms 1 Klatskin Tumor 1 Hypopharyngeal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Small Cell 1 Advanced Breast Cancer 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡